GH3 - GEROVITAL Articles (VIII)
Ana Aslan and Gerovital-GH3®,
the Original and First Anti-Aging Medicine
By Mircea Dumitru MD Ph.D. (by Ana Aslan's personal physician).
was Ana Aslan?
Aslan is renowned for her essential contribution to gerontological
research as well as for having patterned the best geriatric treatment
influencing the aging process. Ana Aslan was the first person to rule
out the fatalistic approach to aging, providing a new method in gerontology
by opening the way to the prevention and treatment of old age.
worked with Professor Ana Aslan for 25 years, from 1963, first as
a researcher, then as chief physician and afterwards as the Director
of the National Institute of Gerontology and Geriatrics in Bucharest,
Romania, between 1978 and 1990.
the last 3 years of her life, Aslan chose me as her personal physician
and three months before her death she asked me to do some personal
things, including to write a book about her life and her work. So
I took notes at her bedside as a moral testament.
addition to her life, she talked of her views of politics, religion,
euthanasia, dying, death and love. As such I had the opportunity to
know her private thoughts and personal thinking.
her 90th solemn birthday celebration at the Romanian Academy in Bucharest
on May 22nd, 1987, on behalf of the Romanian National Institute of
Gerontology and Geriatrics, I said; "I want to express my emotion
and say how difficult it is to talk about Ana Aslan, being such a
complex personality, the story of Gerontology might as well be the
story of Aslan."
Aslan's life can be seen in her work. She has battled courageous fights,
all for the service of good, to make man's dream to live with dignity
for as long as possible. Now we celebrate the inventor, the scientist,
the physician, and the professor. For 35 years since 1952, she has
led us as the first Institute of Gerontology in the world. Ana Aslan
is the Ambassador of Gerontology and a brilliant woman.
a scientist she is an inventor, not an imitator. She has played such
an important role in Gerontology at the world level. She has given
the world decades of research that revealed that Gerovital-H3®
is the most effective treatment in geriatrics. Ana Aslan is the original
contributor in the basic research concerning cellular and molecular
aging, and researching her product reaction in the body.
has a special empathy for the elderly and has always fought to improve
their condition all over the world. She worked with others to initiate
the General Assembly of the United Nations Organization on aging,
held in Vienna, 1983. Aslan has a remarkable understanding and appreciation
for beauty and culture. At one time she visited Hippocrates grave
and on which she stated, "I now realize how small I am."
a disciple and collaborator, and being inspired by the University
Hymn, I declare "Viva Academia! Viva Professores! Viva Ana Aslan!"
Commander of the order "Meritor Della Republica," Italy,
2. Commemorative Gold Medal, Nicaragua, 1971.
3. Cross of Merit, first class Order of Merit, Germany, 1971.
4. Hero of Socialist Labor, Romania, 1971.
5. "Augusto Pinaud," Medal, Venezuela, 1972.
6. Cavalier de la Nouvelle Europe, Prize Oscar, Italy, 1973.
7. Knight of the Order "Les Palmes Academiques," France,
8. International Prize, "Eva," Italy, 1974.
9. Commander of the Order "De Orange Nassau," Holland, 1975.
10. "L'Ordre du Merite," Grande Officier, Senegal, 1976.
11. "Dag Hamarskjoeld," International Prize, Italy, 1977.
12. "Dama di Collare Del Santo Graal," Nice, 1978 (granted
13. Honorary Foreign Citizen and Honorary Professor of Sciences, Manila,
14. President and Honorary Guest of the Symposium, "Ageing Comes
of Age," Philippines Academy, Philippines Association of Geriatrics
and Gerontology, 1978.
15. Officer of the Order "Merito Della Republica Italiana,"
16. La Medaille et le Prix "Leon Bernard" La 35eme Assemblee
Mondiale de la Sante, 1982.
is quoted in all of the following
Who in America (1972) Who's Who in the World (1971) Who's is Who of
Women (1971) British Encyclopaedia (1974) Who's Who of Intellectuals
(1976) The International Men of Achievement (1976) International Biographical
Association of England (1978)
are witnessing a spectacular alteration of the age pyramid. Furthermore
the process of the demographic aging of the population will continue
to increase in the coming decades. I feel obliged to sound an alarm
at the apparition of this phenomenon unique in human history, at least
in relation to how the appropriate tactics and strategies should be
society has the duty to benefit in an organised way from the knowledge,
experience, wisdom and the free time of the elderly.
as a way of life for aging and aged people, creates for them a mental
and physical well being, changing old age into a useful period, not
only at the individual and family level, but at the social level too.
traditional image of the elderly incapable of working, needing help,
care and with a tendency for solitude is being reevaluated. Elderly
people do not appear as a homogenous category of population, but as
a very heterogeneous one, from the demographic, medical and social
concept of the "elderly" from the social standpoint is becoming
outworn and out-of-fashion, and is frequently considered in a merely
functional sense related to the elderly's capacity of assuming a role
in the community.
researches are apt to offer solutions for promoting an Active Old
Age. As a supporter of an optimistic conception of the third age,
in the data that I am submitting, I will propose measures to forming
a new attitude towards this last stage of life.
everlasting ageless youth" has always been one of the great desires
and concerns of mankind. Especially in the latter decades, if the
thoughts of the last thousand years were put into a microscopic lens
then the complex equation of human aging would begin to reveal some
of its unknown values, however man cannot accept the idea of aging
have discussed the topics of aging and old age with my patients during
the last 40 years of my pregeriatric and geriatric practice; these
years having been dedicated to scientific research relating to the
aging diseases; their prevention and treatment.
worked for 25 years at the National Institute of Gerontology and Geriatrics
in Bucharest, of which I was the Director and the closest coworker
of the famous Romanian physician- Ana Aslan for 11 years. I have had
the opportunity to examine patients of different ages from all over
the world, to know their thoughts, their concerns and their varied
example, I've talked with many young people, for whom aging, death
and disease were states, which they hadn't accepted yet as a possibility
during their life. Other young people I have dealt with had diseases
and pain and wished an end as quickly as possible. Some considered
that they ought to try everything as soon as possible and had no respect
for their health.
women believed the menopause was the starting of their old age and
other healthy old (often-centenarian) people who were in full activity
pleaded for the beauty of this age and regarded life from the height
of their wisdom. Of course there were also their children abandoned
those elderly who had severe chronic diseases and were living alone
having. All this has been a fantastic lesson for my pregeriatric and
only fate made me the personal physician of Professor Ana Aslan during
the last three years of her life. During this time we became closer
in spirit and in our long conversations she shared many of her private
thoughts of her life experience fighting against old age and its sufferings.
her many questions that I was concerned about gave me the opportunity
to learn the convictions of one of the most famous personalities in
the world, her ideas were pioneering in the fascinating field of Gerontology
the afternoons and in the evenings on the terrace of her apartment
at the Otopeni Clinic, (where she was convalescing), she told me her
thoughts, and interrupted only by nightingale trills, she talked of
the 84 countries she had visited. The people, their cultures, the
famous personalities she'd met, and normally, about the history of
her only son- GH3 Gerovital-H3®-
the product that could improve the quality of life.
40 years of age (which is a critical period from a biological point
of view), many people begin to ask; "What is old age? What about
the aging process? How can we fight against it? Can old age be delayed
or prevented? What are the factors accelerating the aging process?
Should we learn to die? Has a person the right to dispose of his or
her own life and decide when the end is to be? What about sexual activity
in old age? Can it be improved? How will relations between the generations
be affected? What is the older persons role in society and family?"
and so on.
understanding of the concerns of gerontology schools in the United
States, Great Britain, Germany, France and Romania regarding the "Life
Extension Research" and from my geriatric practice, in time,
I appreciated that "those good habits" give strength and
active life in aging.
we have discovered what was originally thought to be a compulsory
condition of old age, namely the presence of heart disease, arthritis,
diabetes, depression. Presently and especially in the near future
these are (and will) no longer are the facts of aging. Everything
depends on the way you live from birth to death and what kind of supplements
you are taking.
behaviour is based on the way of thinking to remain young, on the
strategy to fight against gaining weight, to prevent paralysis, to
fight against the stress and to maintain a young at heart spirit.
the following pages, I will try to answer some of these questions
and to draw the way to live, remain active and to retain dignity in
grow old in a beautiful and dignified way is at the same time a science
and an art." Ana Aslan.
aging process and old age
Aslan remembered with pleasure a question asked by many reporters
and research workers; "What made you in the 1940's- when very
few people thought about geriatrics- dedicate yourself to the study
of aging and to the care of old people?"
Aslan's answer was always full of nostalgia; "At the age of 50
I changed my career and I started another life dedicated to Geriatrics.
I was a specialist in Internal Medicine and Cardiology and in 1945
on January 1st, I received a congratulation card, which I keep with
my precious possessions. This card was signed by many of my patients
who wrote- On the occasion of your birthday a group of old patients,
some of life's broken toys, wish you good health and many happy years!
- I read and re-read- these words many times and they continued to
stir me and even to obsess me. I told myself, that in fact, these
broken toys could be mended, and I wondered what help I could give
old people? Those words and that card, together with the impulse given
by one of my professor's, were the seed which sprang in my mind and
made me dedicate the rest of my life to the study and treatment of
old people. It was the elderly showed me that TIME is the killer of
organic substance and it puts its definite imprint on the human organism."
our contemporary society, we are witnessing two essential tendencies,
the aging population and the technical progress.
understanding of demographic tendencies, therapy and recovery from
the diseases of old age are priority problems with economical, political
and social implications.
of us is a witness to a spectacular increase of the average life span,
which increased from 40-50 years in the last century, and now, to
more than 78 years old. Grandfathers take care of their grandchildren,
and their great grandchildren, and they share with them their life
experience, a feat not possible before in the history of mankind.
the year 2000 those over 60 years old will represent 15-20% of the
total population of the earth. The rate of those over 65 increased
from 200 millions in 1950's to 400 millions in 1985, and to an estimated
600 millions in 2000, and to more than 1 billion in 2025!
are the implications of the presence of such a segment of elderly
within the population? Should they stay outside of the normal social
life? The answer to these questions has an impact not only on Gerontology,
but in philosophy, religion, politics and economy too. Geriatrics
deals with the medicine for the elderly, and Gerontology studies the
modifications of the human organism in time, as such Gerontology can
define the aging process and can distinguish between aging and disease.
Alone they cannot answer and solve the fundamental aging questions,
but together they become a powerful science.
Aging is a plurality of normal changes of mankind due to the lapse
of time, the change in the frame of mind and in the physical condition
of each of us. * Disease is an accident, a pathological process, abnormal,
which can occur occasionally in childhood, adulthood and is not compulsory
in old people.
can be prevented, treated, or if it becomes chronic it can be alleviated.
Disease can also often hide aging and for this reason we should pay
attention to the change due to time "per se."
aging process is suggestively illustrated in Figure 4. It shows the
increasing presence of aging from the period of embryo, childhood,
adulthood and into old age. In this conception, old age is the last
period of the life, when the aging signs become evident; signs such
as the gerontoxon (or arcus senilis), a degenerative change in the
cornea occurring in persons over the age of 50 and the ceasing of
the menstrual cycle etc.
the reader it is very important to know that aging is subjected to
the influence of genetic and environmental factors. Under the influence
of these factors, the aging rhythm can be normal, accelerated, or
person has his or her own biological clock, which can function normally,
or it may have an accelerated or delayed function.
nutrition, physical, environmental factors, way of life, presence
or absence of diseases, stress and the eutrophic treatment with Gerovital-H3®
influences the aging rhythm.
the age of 40, the proportion between muscular and fat tissue changes.
Around the age of 60- 30% of the muscular mass is replaced by fat
tissue. The articular flexibility, muscular strength, pulmonary ventilation,
vascular elasticity and cardiac efficiency decrease with advancing
acuity and ovarian function are among the first changes, which announce
the period of senescence. In bone structure, important changes take
place, which should be prevented with the necessary steps.
the age of 65 we can no longer do what we did at the age of 30 and
this fact we all understand.
age is often a "state of mind" and the human spirit is the
strongest treatment, which should be fed with understanding, useful
constructive work, love, tolerance, kindness and friendship.
age can be a period of pain, loneliness and disease, with high medical
cost and social complexity; Grieg described it as "diminishing
also has its beauty," Juvenal however, said, "old age is
worse than death."
everyday life, in literature, in fairy tales, old age aureole is not
missing. In popular wisdom, the old man appears as a positive character,
kind and clever. The elderly are capable of useful activities for
themselves and for others, they can solve difficult situations, to
value their creativity. They are a treasure of wisdom and preserve
a "living history," they are the keepers of history, and
by vocation, character and inspired choice, become as much important
I asked Aslan, "what is aging and old age and how do we fight
it?" she answered, "Old age is full of suffering and pain
and I regard this as a parasite of life which develops slowly and
whether you know it or not, it takes hold of us. From the age of 50
onward, I declared war on aging and old age. Gerontology and Geriatrics
have enough possibilities to slow down the aging process and to delay
old age onset. We are obliged to guard against and to explain to healthy
or sick patients, what it means to grow old, and what they have to
do in order to extend their life in conditions of quality. My treatment
and my method is a solution, Gerovital-H3®
is not only a treatment, it is hope, and when there is no hope, there
Aslan's incredible adventure
HER OWN WORDS) "I accepted that I had to leave Bucharest in order
to be by myself. This was not easy for me, but in those years, the
air that I was breathing was not enough. Brilliant lights are attractive
to creative spirits, but they can also deprive you of sight.
magnificent oaks have too much shade, and under their magnificent
crown you can find the smallest trees. Their seeds should be taken
by the wind to fertile places."
Aslan had many personal ideas, one of which was to start a medical
school in Timisoara, the western Romanian town situated on the banks
of the Bega channel.
was here that she met Dr. Pius Branzeu, a student under the famous
Professor Loriche. She discussed his methods of Novocain treatments
on post-operative incisions and later learned about Dos Ghali's method
of intravenous administration of Novocain in patients with bronchial
Aslan passionately studied Professor C.I. Parhon's work as well. After
30 years of clinical and experimental observations, Parhon reached
the conclusion that aging is a disease and that it can be treated.
In 1908 he published his observations of two cases of senile ostemalacia
and in 1925, he introduced the term Ilikibiology, meaning morphological,
chemical and physiological variations related to age.
taught at the medical clinic in Timisoara and learned the basic notions
of gerontology. I read all the works of Marinescu, Parhon, Metchnikoff,
Charcot and Burger (the principle disciples of gerontology) and I
also maintained a relationship with Dr. Parhon. Since 1946, he was
the Director of the Institute of Endocrinology in Bucharest and the
chair of the Endocrinology Department of the University there. I returned
to Bucharest once a month just to talk to him."
was a pioneer in gerontology. He treated aging patients with extracts
of epiphysis, gonads, insulin and vitamin E, in 1909 he published
the first book in the world of endocrinology and in 1955 published
the book Biology of Ages, which was translated all over the world."
had a universal mind and was a wonderful man. Our privileged relationship
was in the field of gerontology; this was where his heart was. He
believed in rejuvenating and ardently maintained that life cannot
be only a one-way direction. He knew everything, botany, zoology,
endocrinology, psychiatry and anthropology. His mind was like an encyclopaedia!
Above all, Parhon was a man of great generosity and dedication. He
sacrificed many things for medicine, even including some family relationships,
he was quite different from Danielopolu but without the two, I would
not be what I am now!"
1946, Aslan published her first research on Novocain, The Novocain
Action on the Respiratory Rate when injected in the Human. "After
the first results with Novocain injections in the vascular embolias,
I tried this treatment on patients with arthosis and those with a
tendency to ankylosis. Because these diseases are chronic, I administered
each with more injections. With great joy, I noticed an improvement
in the local symptoms, and even more importantly, a great improvement
in their overall general condition. Before the treatments, the patients
avoided any movement due to pain, and then they were willing and wanting
to walk, sit up and read, and talk. The biggest reward was to notice
an increase in their interest in life and for their families."
improvements also came along with much more restful sleep for the
patients. This led me to the hypothesis on Novocain's general effect
on the neurophysical system. Maybe it had effects here as well as
locally. I noted these observations for two years until I could test
April 15, 1949, a GI Medical student with arthrosis arrived in our
clinic. For 3 weeks he'd had terrible pains and blocked articulation.
I explained my idea about Novocain to him and after receiving his
permission, gave him an intra-arterial injection with 1% Novocain.
His knee was mobile immediately and he could flex his leg outright.
What happiness! I administered this treatment for another two weeks,
after which he completely recovered."
was a nice park close to the clinic in Timisoara, and one April afternoon
while I was there I noticed an old man. He was leaning on his crutches
and when sitting down, he laid his head in his hands. I later saw
him in one of Van Gogh's paintings! He embodied despair. My attention
then turned to an old couple who was walking with small steps, patiently
leaning on one another. They did not talk, but their dry wrinkled
faces told enough about their many years. Their gait was a symbol
of their fraternity and support they have given, and will continue
to give, to each other for the rest of their lives."
then said to myself, why can't I help these people? Why do they have
to suffer such pain and suffering? If this young man had started to
walk after the injections I had given him, maybe these people could
be helped? They could smile again and regain their own sure steps."
"I did not go to Bucharest at the end of the week as I had been
doing on the weekends.
I returned to this park. All I could focus on was old people. I was
overwhelmed with age; I began to feel an unusual sympathy. Something
had touched me deep down, and I began my quest. At night I thought
about the Novocain shots Loriche had administered around wounds. If
such rapid healing occurred, couldn't it benefit these people as well?
I became obsessed." "After doing pharmacodynamic research
in 1946 with Dr. Danielopolu, this conviction crystallised in my mind
between 1947-1949. I was using Novocain to treat bronchial asthma
according to Dos Gahali's method and to treat arthritis and emboias
according to Loriche's method."
practically ran to Bucharest with my results! Dr. Danielopolu advised
me to share this with Parhon immediately. His words to me were, "Novocain
has an effect on aging. You should carefully carry out this research.
Come back to Bucharest and lead our Experimental Department here.
I'll make all the arrangements, just say you'll come." I agreed
and in a few months I was back in Bucharest."
adventure that began in Timisoara continued in Bucharest. But it was
here that the struggle really began. In order to clear up the Novocain
mechanism of action in arthritis, Aslan followed its effects on experimental
arthritis induced by formaldehyde (according to Seyle-Brownlee's method).
the fall of 1949, I wanted to present my first observations to the
Academy of Medicine. It was then that I realised the envy-taking place
among my colleagues, and how it was increasing. In a chorus, Milcu,
Lupu, Nicolau and Benetato were adamantly against it. "You need
at least 25 cases" they argued. Finally, they refused to include
my research in the agenda being set for the Academy's meetings. It
doesn't matter, I told myself, Alzheimer presented his observations
on a single case, and Hodgkin on only six!"
Parhon left the Institute of Endocrinology, those that followed caused
me much frustration. (They did, however, do one good thing, for which
I want to thank them, they agreed with my resignation and return to
the passing of time I learned that the opposition made me more and
more ambitious. I knew that I was right and I had to prove it. Life
would be too dull without controversy, and in my case, unfortunately,
the controversies overstepped the bounds of academic dispute. All
of this doesn't matter now, I forgave them many years ago."
was the co-operation with Parhon that does matter. He was very good
to me and was convinced by the results I was obtaining. He was my
moral support, and it is because of him that I continued with my research."
soon as Aslan began publishing and sharing her method, more and more
people, most of them ill, started to visit the Institute. The Institute,
situated in an anonymous place, gradually became the Mecca of the
came to learn from her as well as to undergo treatment. Some remained
perplexed, listening to the testimonies of the old people who had
regained the joy of life, returned to their favourite activities,
found peace in their battles with insomnia.
importantly, they found their place in society, a society who before
had alienated and repulsed by them. Their spoken and written words
are proof of the effectiveness of her treatment, method and product,
Gerovital H3®, which had bought so much relief and hope to the
physicians came to the Institute for training in gerontology and geriatrics,
and to learn Aslan's method. In return, Aslan visited them in their
countries to acknowledge and celebrate their results. With special
appreciation, she remembered Dr. Marion Bucker Bode of Germany. Besides
leading a center of geriatrics, she also had serious concerns for
research. She talked also of Dr. Pop Michel of Cyprus, these and many
others, were considered her disciples in the fight against aging.
of the many testimonials
visiting the Institute in September of 1958, Academician R. Bacov,
Director of the Pavlov Institute in Moscow, wrote, "I found the
activity carried out at the Institute of Professor Aslan to be very
interesting. The problem they focus on fascinates the world. I think
Professor Aslan has found a real way to maintain the activity of the
nervous system and to prolong the normal functioning of the entire
organism. I myself am convinced that Aslan's method is a success.
Thank you for the wonderful demonstration of your results."
A. Homes, MD, chief physician in a hospital in Washington D.C., confessed
that he learned much from Aslan's revolutionary treatment. Hollings
E., Senator S.C., Washington D.C., expressed his admiration for a
real mother nature, as well as Senator Howard W. of Nevada, who remarked
on the wonderful work in such an important field.
Aslan thoroughly studied and diversified the research, a fact that
was noted in the pharmacology department of Harvard University as
were world-wide acknowledgements, the Minister of Health in Belgium,
Nameche Louis, stated that he was "impressed by the social action
developed by Aslan and convinced of the prophylactic results."
since 1966, Lord Amulree of London appreciated "the work Aslan
developed in order to cover all of Romania with a network of care
centers for the elderly. These could very well be imitated by other
countries and I hope this wonderful work by Professor Aslan will be
very wide spread."
Iderwal de Carvalbo, Professor of psycho-pathology at the Sao-Paulo
University in Brazil was "full of admiration for all he saw and
felt at the Institute when he personally noted the stateliness of
Aslan's work and the magnificent results in treating aging with GH3
Gerovital H3 ® and Aslavital."
the Institute of Geriatrics and Gerontology of the University of Florence,
Italy, Professor Francesco Antonini, "admired the work carried
out with such intelligence." A letter of gratitude from Professor
Mario Giacorezzo from the Medical Clinic of Rome University, thanked
Aslan "for this masterly lesson."
writers and poets whose fantasy took them beyond the limits of reality
soon visited the Institute seeing the results in old patients. For
example, Galina Seredrinkova wrote, "Faust's dream, the alchemists
fight for life has been solved by the well known woman of our century,
Ana Aslan. The gratitude and enthusiasm towards her talent and her
deep scientific thinking includes anybody between the walls of her
news journalist by the name of A. Umar, considered Aslan's results
not only prestigious for Romania, but for the entire world.
her life, Aslan received thousands of letters. They came from the
most remote parts of the world. Sometimes the letters were directed
with no address, but a simple "Ana Aslan" on the envelope.
The country and address was not necessary, the entire world knew of
her! In most letters, patients expressed their thanks, for regaining
strength, hope and confidence. They expressed their gratitude for
her competence and devotion.
had four secretaries who helped her answer each and every one. They
had a difficult job, working in the rhythm and time that Aslan demanded.
She did not consider this impressive correspondence as simple politeness
and responsiveness, but rather as a constitutive part of her own medical
activity as a doctor. The exchange with research institutes, such
as the "Institute of Aging" in the United States and in
Kiev, meant contact.
her travels and fame, Aslan made friendships everywhere. Many of them
became patients and followed her treatment for years and years. One
of these was Mr. Hans Matguart of Germany; he was a man of remarkable
culture, honour and honesty. After he learned of Aslan's death (a
month after she had actually died), he took a plane to Bucharest.
He went to her grave and quietly remained there for some time, as
homage and out of respect.
went on to address me; "It is a pleasure for me to speak about
Professor Ana Aslan, as she was, in my opinion, a world authority
and a remarkable person. My first encounter with her took place in
1982. Ana was herself an old woman, but yet maintained all of her
mental capacity. Her long medical experience proved very useful. Ana
was also being treated with Gerovital-H3®.
Her intellectual capacity, maintained to the end of her life, is proof
of the drug's success." "I had begun my treatment (Aslan's
therapy) on August 12, 1980 and continued without an interruption.
herself personally cared for me. She examined me and decided on which
type of therapy. For ten years, at regular intervals, I have been
treated with Gerovital-H3®
by injections and by pills. I am now 76 years old; therefore I started
therapy when I was 65. Since then, I have continued leading negotiations
in my field and making all the necessary decisions about my activities.
Would I still if I wasn't using Gerovital-H3®? I definitely say
the last 10 years I have accomplished my daily tasks with great joy.
When we think that the normal man retires at 65 or earlier, then these
10 years are even more astonishing. I have held honorary positions
and been appointed several times as president of different organisations.
This activity is proof of my capacity. It should also be mentioned
that in the last 10 years I have also had no serious disease, more
proof of healthy conditions due to Aslan's therapy."
these 10 years I have often talked with others in this long term treatment,
and not once have I heard a negative word. Of course this therapy
cannot make miracles alone. Positive results only appear when regular
treatments are given and the physician one is dealing with is seen
all, I hope her knowledge will be spread to all the people in this
country and to all of human-kind."
this visit, Mr. Matquart was intrigued and puzzled about why her death
had not been immediately announced. "Ana belonged to mankind,
not only to Romania. Surely, Belu cemetery would have been full with
people from all over the world?" But under communism, the people
of Romania had no possibility to taste and to know of Ana Aslan's
basis of GH3 Gerovital-H3® treatment
Aslan at the Institute of Gerontology and Geriatrics in Bucharest,
Romania experimented with Gerovital-H3® between 1951 and 1958.
Since 1951, Aslan stopped the use of hydrochloric-procaine; the research
results materialised a different product with a new formula- Gerovital-H3®.
In the new formula, adding benzoic acid to procaine and inducing a
greater access of procaine into the hydrophobic cellular compartments
modified the pharmacological action of hydrochloric-procaine.
Gerovital-H3® and hydrochloric-procaine there is a difference
of pharmacological action. Hazard showed that the procaine-based product
has a stability of 6-months, whereas the Aslan product has a much
increased stability of 2 years and 6-months.
introduced into the human body, the procaine molecule is hydrolysed
by procainestherase into two metabolical fractions; Paraaminobenzic
acid (PABA) and Diethylaminoethanol (DEAE). The absorption of the
two metabolites is better when they result from the in-vivo hydrolysis
of Gerovital-H3® than administered as
such. The absorption takes place in a competitive manner, which means
that the two metabolites compete for the active sites or mechanism
that govern the absorption. The DEAE's absorption is particular to
the brain as compared to other organs.
procaine from Gerovital-H3® has a greater capacity of wadding
the medium (pH), due to benzoic acid, reducing the degradation speed
of the product. DEAE splits into Ethanolamine, Glycine and Urea. Ethanolamine
enters the synthesis cycle of Choline and then acetylcholine. In the
case of Gerovital-H3®, the chromatographic techniques showed that
there are intact procaine molecules in the blood and heart of experimental
animals 6 hours after the product was administered. There are two
possible explanations for the important difference in the procaine
is considered that hydrochloric-procaine is differently metabolised
depending on the pH of the solution. At a pH of 7, the procaine is
permeated "en mass" into the blood, but at a pH of 3.3 the
procaine is gradually set free from the blood.
acid solution will decrease the sudden release of the substance, a
quality that Gerovital-H3® possesses.
Cohen (1) shows that benzoic acid will arrange itself in space in
such a manner that it protects the procaine molecule at its weak point
from the action of procainestherasis. Important are also the K ions,
which amplify the procaine action at the level of the nervous, and
the muscular system (2). Gordon (3) has compared Gerovital-H3®
and Procaine and found that there are significant statistical differences
in favour of Gerovital-H3®. The experiments carried out by Aslan
(4) showed significant differences between Gerovital-H3® and Procaine
inducing the vascular conditioned and unconditioned reflexes in old
acts upon the human body both under the form of an intact molecule
and through the hydrolysis products PABA and DEAE, which participate
in the regulation of the intermediary metabolism.
favours the acetylcholine synthesis and it is a source of folic acid.
In fact, a series of researches suggest the hypothesis that procaine,
by means of the PABA, can stimulate the intestinal flora and the production
of folic acid, vitamin K and tyramine. The cellular effect of the
Aslan product bears different characteristics and dimensions regarding
the organ in question and its role within the body. The improvement
of the superior nervous activity presents a particular importance.
Yau (4) made a pharmacological study upon Gerovital-H3® and summarised
its basic mechanism as,
competitively and reversibly inhibits monoamineoxidase (MAO).
*Gerovital-H3® acts as an antidepressive through the modification
of the monoamine level in the brain.
*Gerovital-H3® is very selective in the oxidase desamination inhibition.
*Gerovial-H3's oxidative desamination of monoamine is done in such
a way as to eliminate the hyper-blood-pressure peak, so typically
present after administering of other MAO inhibitors.
is considered to play a role in maintaining the physiological status
of the nervous cell membrane, restoring the equilibrium between the
processes of excitation and inhibition at the level of the cortical
and subcortical systems.
*Gerovital-H3® exerts an important regulatory action upon the
nervous vegetative centers. Further experiments reveal procaine's
anabolic action. Studies on Infusoria (Colpidium colpoda and Vorticella)
show the proliferation of cells as a result of a weak procaine solution
investigations on rats drew the attention of procaine's anabolic affects
improving the quality of the hair. Berger obtained similar results
with 6mg procaine / Kg body weight in a study on 3-month old rats
(7). On the other hand, Verzar used 25mg procaine / Kg body weight
(the amount which inhibits oxidoreduction) and did not notice any
modification (8). In order the solve these contradictory results,
Aslan initiated a study on 1800 white rats treated with Gerovital-H3®
(9). The results pointed out an improved general tropicity, an increased
resistance to pulmonary disease and less myocardial modifications.
Fewer spontaneous tumours occurred in the treated group as compared
against the controls.
action upon the lipid mechanism is reflected by the lypotrope, heparinoid
and lypoconverting characteristic (10). Aslan's procaine-based product
exerts its effects on the atherogenesis process by several mechanisms;
diminishes the level of plasmatic lipoproteins and lipids.
*Gerovital-H3® exerts an effect on the erythrocyte membrane (an
increase in membrane fludity and a protection against osmotic hemolisis).
*Gerovital-H3® has an anti-oxidant mechanism that reduces the
oxidative stress exerted on the membrane structure. Russu et col.
Found that Gerovital-H3® exerts an inhibition on the generation
of the superoxide radical in a non-enzymatic system (11).
has been shown that Gerovital-H3® action on the lipid metabolism
results in modifications in the serum total cholesterol, changes of
the lipoprotein fractions ratio and changes to the unsaturated fatty
acids content (11).
must be made of the fact that the research concerning Gerovital-H3®
therapy has been simulated in over 500 medical and scientific publications.
experiments utilising the original Aslan product and method confirm
the efficiency and efficacy of Gerovital-H3®.
data presented at the 10th Congress of the International Association
of Gerontology in Jerusalem in 1975, and at the European Congress
of Clinical Gerontogy in 1977, made available new evidence of the
efficiency of Gerovital-H3®.
work of the special session at the Jerusalem Congress regarding old
age pharmacology were dominated by the research focussed upon the
mechanism of Gerovital-H3® action.
special interest was generated by the mechanism of Gerovital-H3®'s
action, particularly from several American scientists who presented
papers of double-blind placebo controlled trials. Among them was Professor
William Zung from Duke University, North Carolina who in his study
applied the treatment for 28 days on his patients who were suffering
from depression (12).
group of patients aged 60 were submitted before, during and after
the treatment to a battery of psychological tests. Professor Zung,
a well known and respected author of psychological tests, proved the
GH3 efficiency in the treatment
of depression. Within the same session, the American authors, M. Kurland
and M. Hayman from Palm Springs, California, presented the double-blind
results performed with Gerovital-H3® on 63 patients suffering
from depression and aged 45 to 80 (33 using Gerovital-H3® and
30 using placebo). Under observation there were several types of depression;
manic-depression, reactive depression, organic cerebral depression,
chronic reactive depression and alcoholic depression.
results proved that Gerovital-H3® efficiency in all the tests
applied, the differences between the two groups showed a great statistical
valuable results were communicated by McFarlane MD who proved that
MAO (13). It is a known fact that the MAO levels increase with advancing
age (14). McFarlane certifies the lack of any adverse reactions with
Gerovital-H3® and he also confirmed that Gerovital-H3® is
a reversible and competitive MAO inhibitor.
success enjoyed by Gerovital-H3® at the Jerusalem International
Congress in June 1975, was remarked upon by Professor Nathan Shock
(USA) in the closing speech of the Congress. That recognition came
shortly after another world-wide known gerontologist, Alex Comfort
(England), in an article published in the magazine "Mechanism
of Ageing and Development", where he made positive remarks upon
Gerovital-H3® and Aslan's method.
the occasion of the International meeting "Medizinischewoche"
in Baden Baden, Germany in November 1983, whilst concluding the Gerontology
and Geriatrics section, Professor Paul Luth said "The Aslan method
and treatment represent the most efficient therapeutic producure in
method of prophylactic and curative treatment with
a medical professor from 1947 to 1949, Ana Aslan was inspired by the
works of Lorich. Aslan started administering procaine in cases of
arthritis and in trophic troubles of the extremities with sometimes
spectacular results (1).
is what Ana Aslan declared from the very beginning; "After one
injection in the femural artery given to a patient with embolism at
the level of the inferior extremity, I noticed the almost instantaneous
disappearance of pain. Then, for the first time, I had the idea of
applying the same method in certain diseases with acute pain, which
produce immobilization and thus long-lasting work incapacity."
other great discoveries, the clinical observation facts did not fail
Aslan, as they represented the beginning of a period of original and
fundamental studies which contributed to the prophylaxis and treatment
of aging and chronic disease. Thus, in that period, another clinical
observation was pointed out by the patients who stated that after
the injections (given into the artery of the extremities), pain was
relieved in all the body. "I believe, a general effect was obtained,"
in 1949, Aslan began applying her treatment in a nursing home. Besides
an improvement of the local phenomena, she noticed that the physical
and psychical state of the old men was becoming better. That was the
time when Aslan initiated experimental research which had particularly
favourable effects on all the treated animals.
want to emphasize that, besides introducing the procaine treatment
against the aging process and degenerative illnesses Aslan had other
original contributions lying at the base of the treatment and method
bearing her name.
introduced long-term procaine therapy.
*Aslan used procaine in intramuscular injections according to her
own schedule, which represented a true therapeutic novelty, since
previously procaine had only been used for local anaesthesia, or in
short-term cures injected either subcutaneously, intravenously or,
more rarely, intra-arterially.
special moment arrived when procaine was prepared to the new formula
now known as Gerovital-H3®. This is more active and has practically
no side effects if administered in therapeutic doses.
was experimented with at the Institute of Gerontogy and Geriatrics
in Bucharest, between 1951 and 1958. In 1957, Aslan started comparative
investigations to establish the effectiveness of the oral treatment.
To achieve the same results like in the parentral treatment, the oral
dose has to be doubled.
must also state that at the Bucharest Institute, to evaluate the effects
of Gerovital-H3® treatment, since 1952,
a clinical study has been initiated. This study, due to the thousands
of patients observed over a 25 year time scale makes this clinical
study unique in the world. Gerovital-H3® is a complex drug acting
like the procaine molecule with its two hidrolisis products; PABA
and DEAE. The addition of benzoic acid, potassium and disodium phosphate
increase the effects of Gerovital-H3® biotrophic treatment.
is indicated for people older than 40 years in order to retard the
aging process and as a preventative and curative treatment for chronic
degenerative diseases. Gerovital-H3® has been shown to be efficacious
in all the following;
and light depressive states.
*in troubles concerning attention, concentrating, cognitive processes
and in balancing the neurovegative distinies.
*chronic fatique syndrome.
*tegument distrophias, trophic ulcers, atonic wounds.
*osteoarthritis, degenerating rheumatism, osteoporosis and during
fracture consolidation periods.
*sexual management and improving sex drive
an active anti-aterogenous factor and recommended in cerebral and
peripheral artherosclerosis and in the treatment of post-infarct and
*Parkinson and Parkinson syndromes.
*Gerovital-H3® ameliorates the hair resistance and quality, repigmentation,
reduces the alopecia (hair loss), head skin seborrhea and helps eliminate
*due to the inhibition on the generation of the superoxide radical,
Gerovital-H3® is a powerful antioxidant, a free radical quencer.
of Gerovital-H3® treatment
treatment produces a general transformation of the organism manifested
*desire to be active and to live, better memory, enhanced concentration
ability and attention, improved optimism.
*improved affective tone and psychic and vegetative balance.
*increased self-caring abilities and exercise capacity.
*more ability to cope with the environment and increased resistance
*balanced endocrine functions with oestrogens reappearance and androgen
*improved visual, auditive and olphactive acuity.
*diminished extrapyramidal rigidity, improved gait and increased mobility.
*better skin, nails and mucous trophicity.
*hair growth stimulation with a tendency to repigmentate the hair
and a more trophic aspect.
*better blood vessel reactivity.
*the alleviation should also be mentioned of the clinical symptoms
of the chronic diseases; chronic rheumatism, atherosclerosis, bronchial
asthma, psoriasis, vitiligo, varicose ulcers.
*improves the quality of life retarding the rhythm of aging and preventing
the chronic diseases.
*improves the sex drive.
method for Gerovital-H3®
long term treatment with Gerovital-H3® has been extensively established
with Aslan et col. For over 40 years at the National Institute of
Gerontogoy and Geriatrics in Romania, in compliance with Aslan's methods.
the beginning, Gerovital-H3® was administered only as injections.
The tolerance has always been tested before starting the treatment;
one subcutaneous injection of 1ml on the first day, followed by an
intramuscular injection of 2ml the next day.
no local or general reactions occur, proper treatment can be started.
In the experience of more than 300,000 patients that completed this
treatment in Romania, an intolerance only occurred in 1 in 7000 cases.
1957, Aslan started clinical and experimental comparative investigations
in order to establish the effectiveness of the oral administration.
dose of active substances had to be doubled to achieve the same results
as in the parenteral treatment. Considering this fact and the difficulty
raised by the accurate management in certain patients, Aslan established
a combined schedule made up of both oral and parenteral approaches
Treatment of chronic diseases and aging consists of 4 courses of 12
injections and 4 courses of 24 pills, ie, one course of 12 injections
over 4 weeks (ie, 3 injections per week), a 4-week break then one
course of 24 pills over 12 days (one pill twice daily between meals),
a 2-week break and then the cycle is resumed.
from the age of 40 years, the prophylactic treatment with pills only
is recommended in a series of 25 tablets during the first 12 days,
with an interval of 2 months; 1st day, 1 tablet/ day, 2-hours after
breakfast, increasing to the 12th day when 2 tablets per day are taken,
(again 2-hours after meals, for example one at 10AM and another at
4PM). There should a series of 5 treatment courses in the year, which
should be increased to 6 per year for persons over the age of 65.
Treatment in chronic diseases requires 6 course of 12 injections,
and 5 courses of 24 pills, yearly, ie, one course of 12 injections
over 4 weeks, a 2-week break, one course of 24 pills over 12 days
(one pill twice daily between the meals); 2 week break. The cycle
is then resumed.
upon the outcomes the physician and patients can either shorten or
extend the breaks. The first and second course of injections can be
administered daily in order to study the individual reactivity.
treatment can be individualised according to the disease/ diseases
accompanying the aging and the patients biological age.
arteritis, actively influenced by Gerovital-H3®, the route of
administration is intra-arterial. Aslan recommended the intra-arterial
route in arthrosis and arthritis, especially when the knee joint is
involved, and the intravenous route for cerebral spasms.
should be avoided by anyone suffering or utilising the following;
*allergy or sensitivity to Gerovital-H3® (or Novocain).
*Gerovital-H3® cannot be used together with eserine or prostigmine.
*Gerovital-H3® can not be used at the same time as sulphamides.
*Gerovital-H3® should not be used with an antibacterial treatment.
side effects are relatively uncommon and may occur principally only
after injections, but the frequency is very reduced (according to
the statistics there is 1 case for every 7000 patients).
minor side effects consist of a heating sensation and metallic taste,
these effects disappear during the treatment.
major side effects are related to the skin; macular eruption, rash
and itching which determine the interruption of the treatment and
the remake of the tolerance test (1ml injected id.) after the eruption
has disappeared. The treatment of the side effects consist of the
administration of the usual antiallergic drugs if the eruption persists
after the arrest of Gervotial-H3.
spite of its monoamineoxidase (MAO) inhibitor character, Gerovital-H3®
does not interfere, as the convential MAO inhibitors do, with the
Tyramine from food (ed.- commonly called the cheese affect), which
means there is no known incompatibility with Gerovital-H3® and
food. The interaction with sulphamides is because of the competition
on the bacterial metabolism. Overdose may occur only after 400mg in
iv rapid injection and the treatment is the same as for any acute
(1). Loriche R., Lafontaine R.: De l'emploi des injections intra-arterielle
de novocaine dans les formes daouloureuses des obliterantes. Presses
Medicale, 1953, 17:327.
would like to thank Dr. Dumitru for bringing up to date the monography
of Gerovital-H3®. We should all be grateful to Professor Ana Aslan's
work, as she helped to bring to the attention of the world the fact
that aging is a disease and like any disease it is treatable! Even
today, Gerovital-H3® remains at the fore-front of many life-extensionists
programs. This is perhaps not surprising (as Dr. Dumitru has pointed
out here) when you consider that Gerovital-H3®
has such a myraid of profound uses, both for preventative and curative
purposes. This coupled with its extremely low toxicity and few, minor
side effects means that Gerovital-H3® presents itself as an essential,
safe and very long term anti-aging supplement for those who are serious
about administering their aging condition.
Cohen S., Ditman K.S. Effects of Gerovital-H3® on Elderly Depressive
Patients. Int. Smposium of Gerontology, Bucharest, 1972.
(2). Teitel A., Gane P., Stroescu V., Steflea D., About the Mechanisms
of Procaine. Studies of Fisiology, Bucharest, 1962, 4, 351-360.
(3). Gordon P., Fudema A., Abrams A., Effects of Romanian and American
Procaine Preparations on Certain Physiological Aspects of Aging. Gerontologist
II, 1962, p.9, Gerontologist, 1965, 20, 2, p114-150.
(4). Ana Aslan; Gerovital-H3® Therapy in the Prophylaxis of Ageing.
Rom. J. Geront. Geriatrics. Bucharest, 1980, 1,1 p5-15.
(5). Yau M.T. Gerovital-H3®, Monoamineoxidase and Brain Monoamines.
Symposium on Theoretic Aspects of Aging, 1974, Miami, Florida.
(6). Parhon C.I., Ana Aslan, L'action de la Vitamine H1 et H2 sur
la proliferation de la cellule animale. Bull. Acad. Rom. Bucharest,
1957, 9,1, 137.
(7). Berger P; Innocuite du traitment chronique a la procaine chez
le rat en croissance. C.R. So. Biol. 1960, 154,959.
(8). Verzar F. Note on the influence of prcaine, PABA and DEAE on
the aging of rats. Basel, 1959, Gerontology 3,6, 350-355.
(9). Ana Aslan et col. Long term treatment with Gerovital-H3®
in Albino rats. J. Gerontology, 1965, 20,1.
(10). Ana Aslan, G. Enachescu. Reseaches on the Anti-thrombophilic
activity of Gerovital-H3® treatment. Rom. J. Geront. Geriatrics,
180, 1, 2, 195-246.
(11). Russu C et col. Antioxidant and lipid lowering effect of original
procaine based product Gerovital-H3®. Book of abstracts. The 16th
Congress of the Internatonal Association of Gerontology, p217.
(12). Zung W.W.K., Wang H.S. Clinical trials of Gerovital-H3®
in the treatment of depression in the elderly. 10th Int. Congress
of Gerontology, 1975, Jerusalem.
(13). McFarlane MD Gerovital-H3® therapy; Mechanism of inhibition
ofmonoamineoxidase. J. of American Geriatrics Society., 1974, XXII/8,
(14). Robinson D.S. et al; Aging, monoamine and monoamineoxidase levels,
1972, Lancet, 1, 0290.
(15). Luth P. Aslan therapie mit Gerovital-H3®. Zeitschrift fur
Algemenmedizin, 1984, 60, 27, p1162-1164.
THE FOLLOWING ARTICLE IS EXTRACTED FROM THE COPYRIGHT PROTECTED
INTERNATIONAL ANTIAGING SYSTEMS BULLETIN. IT IS INTENDED FOR PRIVATE
VIEWING ONLY AND CANNOT BE COPIED WITHOUT THE WRITTEN PERMISSION
OF IAS. DISCLAIMER: ALL INFORMATION IS EDUCATIONAL AND PROVIDED
UNDER IAS TERMS & CONDITIONS. IT DOES NOT, AND SHOULD NOT, REPLACE
THE ADVICE OF YOUR PHYSICIAN